1. Home
  2. ACHR vs GKOS Comparison

ACHR vs GKOS Comparison

Compare ACHR & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACHR
  • GKOS
  • Stock Information
  • Founded
  • ACHR 2018
  • GKOS 1998
  • Country
  • ACHR United States
  • GKOS United States
  • Employees
  • ACHR N/A
  • GKOS N/A
  • Industry
  • ACHR Aerospace
  • GKOS Medical/Dental Instruments
  • Sector
  • ACHR Industrials
  • GKOS Health Care
  • Exchange
  • ACHR Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • ACHR 4.4B
  • GKOS 5.1B
  • IPO Year
  • ACHR N/A
  • GKOS 2015
  • Fundamental
  • Price
  • ACHR $8.67
  • GKOS $90.36
  • Analyst Decision
  • ACHR Strong Buy
  • GKOS Strong Buy
  • Analyst Count
  • ACHR 9
  • GKOS 13
  • Target Price
  • ACHR $11.61
  • GKOS $135.15
  • AVG Volume (30 Days)
  • ACHR 19.8M
  • GKOS 1.1M
  • Earning Date
  • ACHR 05-12-2025
  • GKOS 04-30-2025
  • Dividend Yield
  • ACHR N/A
  • GKOS N/A
  • EPS Growth
  • ACHR N/A
  • GKOS N/A
  • EPS
  • ACHR N/A
  • GKOS N/A
  • Revenue
  • ACHR N/A
  • GKOS $404,523,000.00
  • Revenue This Year
  • ACHR N/A
  • GKOS $27.84
  • Revenue Next Year
  • ACHR N/A
  • GKOS $27.88
  • P/E Ratio
  • ACHR N/A
  • GKOS N/A
  • Revenue Growth
  • ACHR N/A
  • GKOS 23.92
  • 52 Week Low
  • ACHR $2.82
  • GKOS $77.10
  • 52 Week High
  • ACHR $12.48
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • ACHR 57.96
  • GKOS 47.66
  • Support Level
  • ACHR $8.23
  • GKOS $84.26
  • Resistance Level
  • ACHR $9.02
  • GKOS $92.27
  • Average True Range (ATR)
  • ACHR 0.47
  • GKOS 3.86
  • MACD
  • ACHR 0.07
  • GKOS 0.66
  • Stochastic Oscillator
  • ACHR 68.73
  • GKOS 65.16

About ACHR Archer Aviation Inc.

Archer Aviation Inc advances the benefits of sustainable air mobility. The company is engaged in designing and developing a fully electric vertical takeoff and landing eVTOL aircraft for use in UAM networks. It is creating an electric airline that moves people throughout cities in a quick, safe, sustainable, and cost-effective manner.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: